6NOV
A Fab derived from ixekizumab
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 31-ID |
| Synchrotron site | APS |
| Beamline | 31-ID |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2010-11-29 |
| Detector | RAYONIX MX225-HS |
| Wavelength(s) | 0.9793 |
| Spacegroup name | P 21 21 2 |
| Unit cell lengths | 118.404, 197.497, 44.540 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 19.870 - 2.140 |
| R-factor | 0.24 |
| Rwork | 0.238 |
| R-free | 0.27800 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.150 |
| Data reduction software | MOSFLM |
| Data scaling software | SCALA (3.3.16) |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.7) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 41.688 | 41.688 | 2.140 |
| High resolution limit [Å] | 2.050 | 7.100 | 2.050 |
| Rmerge | 0.040 | 0.793 | |
| Rmeas | 0.146 | 0.046 | 0.921 |
| Rpim | 0.055 | 0.019 | 0.340 |
| Total number of observations | 467195 | 10359 | 58367 |
| Number of reflections | 66339 | 1700 | 8034 |
| <I/σ(I)> | 8.1 | 18.1 | 2.1 |
| Completeness [%] | 99.4 | 94.5 | 99.9 |
| Redundancy | 7 | 6.1 | 7.3 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 294 | 28% PEG 5000 MME/100 mM MES (pH 6.5)/200 mM ammonium phosphate |
